Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases
To access this article, please choose from the options below
PII: S0303-8467(10)00052-1
doi:10.1016/j.clineuro.2010.02.008
© 2010 Elsevier B.V. All rights reserved.
